CJC-1295 Spray (5MG)

CJC-1295 in pre-reconstituted spray format, the same long-acting GHRH-analog research peptide as our 5mg lyophilized standard, supplied in a spray bottle for laboratory protocols where on-site reconstitution is impractical.

Format rationale

Spray-format references streamline workflows when CJC-1295 is screened alongside related GHRH analogs. The spray retains the same DAC-modified GHRH-analog peptide chemistry as the lyophilized standard, pre-dissolved in a pH-buffered isotonic vehicle.

Synthesis & verification

The active peptide is produced by solid-phase peptide synthesis using Fmoc protecting-group strategy in a U.S.-based ISO 9001:2008 facility with the DAC modification incorporated post-cleavage, then verified post-formulation for identity (LC-MS), purity (reverse-phase HPLC-UV ≥99.0%), and concentration.

Storage & handling

Pre-reconstituted sprays remain stable at 2-8 °C in original packaging for the printed shelf life. Protect from light, avoid freeze-thaw, and store upright.

Why BioFusion

The DAC modification is technically demanding; under- or over-modified batches are common failure modes for low-cost suppliers. BioFusion verifies modification stoichiometry by LC-MS at every release. Bulk discounts at three+ units; members save 25% plus complimentary U.S. shipping for 365 days.

For research and laboratory use only. This product is not a drug, food, or cosmetic, and is not intended for diagnostic, therapeutic, or in vivo human use.